Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
3254 Pressance
- 1999
- +25+1.27%
20min DelayMarket Closed Dec 30 15:30 JST
139.72BMarket Cap6.59P/E (Static)
2028High1976Low81.90KVolume1980Open1974Pre Close163.68MTurnover204752wk High0.38%Turnover Ratio69.89MShares161152wk Low203.36EPS TTM43.25BFloat Cap2171Historical High6.59P/E (Static)21.64MShs Float90Historical Low303.52EPS LYR2.63%Amplitude45.00Dividend TTM0.71P/B100Lot Size2.25%Div YieldTTM
Pressance Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.05%180.75B | -9.83%41.89B | 4.61%40.96B | 11.09%161.31B | -0.08%40.14B | 6.94%35.56B | 33.59%46.46B | 5.80%39.16B | -40.44%145.21B | -18.74%40.17B |
| Cost of revenue | 13.32%135.06B | -10.52%30.12B | 3.19%29.57B | 8.60%119.18B | -2.82%30.81B | 4.10%26.06B | 28.34%33.67B | 7.01%28.66B | -44.16%109.74B | -26.01%31.7B |
| Gross profit | 8.45%45.69B | -8.01%11.77B | 8.48%11.39B | 18.79%42.13B | 10.18%9.33B | 15.58%9.5B | 49.74%12.8B | 2.65%10.5B | -24.98%35.46B | 28.51%8.47B |
| Operating expense | 8.91%18.07B | -6.45%4.15B | -2.41%3.6B | 12.05%16.59B | 63.93%4.18B | -4.09%4.3B | 15.12%4.43B | -6.20%3.69B | -15.39%14.81B | -37.36%2.55B |
| Staff costs | 17.03%7.03B | ---- | ---- | 8.84%6.01B | ---- | ---- | ---- | ---- | 18.03%5.52B | ---- |
| Selling and administrative expenses | 9.39%5.89B | ---- | ---- | 1.24%5.38B | ---- | ---- | ---- | ---- | -35.42%5.31B | ---- |
| -Selling and marketing expense | 9.39%5.89B | ---- | ---- | 1.24%5.38B | ---- | ---- | ---- | ---- | -35.42%5.31B | ---- |
| Depreciation and amortization | -0.74%135M | ---- | ---- | 16.24%136M | ---- | ---- | ---- | ---- | 14.71%117M | ---- |
| -Depreciation | -0.74%135M | ---- | ---- | 16.24%136M | ---- | ---- | ---- | ---- | 14.71%117M | ---- |
| Other operating expenses | -0.97%5.02B | ---- | ---- | 31.37%5.07B | ---- | ---- | ---- | ---- | -14.18%3.86B | ---- |
| Operating profit | 8.15%27.61B | -8.84%7.63B | 14.38%7.79B | 23.63%25.53B | -12.95%5.15B | 39.10%5.21B | 78.11%8.36B | 8.18%6.81B | -30.61%20.65B | 134.77%5.92B |
| Net non-operating interest income (expenses) | -32.20%-624M | -48.24%-126M | 13.87%-118M | 16.61%-472M | 17.69%-121M | 16.23%-129M | 12.37%-85M | 18.45%-137M | 24.73%-566M | 6.37%-147M |
| Non-operating interest income | -83.72%7M | -95.12%2M | --0 | -29.51%43M | 100.00%2M | --0 | -31.67%41M | --0 | 1,425.00%61M | -50.00%1M |
| Non-operating interest expense | 22.52%631M | 1.59%128M | -13.87%118M | -17.86%515M | -16.89%123M | -16.23%129M | -19.75%126M | -18.45%137M | -17.06%627M | -6.92%148M |
| Net investment income | 290.00%39M | -60.00%4M | 126.09%6M | -96.30%10M | -85.71%4M | -82.57%19M | -89.01%10M | -154.76%-23M | 382.14%270M | -79.26%28M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -119M | 0 | ||||||||
| Income from associates and other participating interests | 840.28%677M | 2,063.89%707M | -103.67%-4M | -81.49%72M | 129.41%5M | -109.09%-6M | 59.09%-36M | -74.53%109M | 204.29%389M | 96.46%-17M |
| Special income (charges) | 1,873.61%1.28B | -133.33%-5M | -5M | -56.52%-72M | -143.24%-90M | 3M | 168.18%15M | 0 | -127.22%-46M | -1,133.33%-37M |
| Less:Restructuring and mergern&acquisition | ---1.26B | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -252.44%-125M | ---- | ---- | 148.48%82M | ---- | ---- | ---- | ---- | 112.50%33M | ---- |
| Less:Write off | 1,140.00%104M | 133.33%5M | --5M | -176.92%-10M | 100.00%8M | ---3M | -168.18%-15M | --0 | -86.32%13M | 0.00%4M |
| Other non-operating income (expenses) | 37.94%349M | 229.41%112M | 45.16%45M | 123.89%253M | 36.67%123M | 103.13%65M | -10.53%34M | 165.96%31M | -76.36%113M | 157.32%90M |
| Income before tax | 15.83%29.33B | 0.14%8.32B | 13.63%7.71B | 22.39%25.32B | -13.07%5.07B | 35.82%5.16B | 84.76%8.31B | 3.41%6.79B | -29.49%20.69B | 214.17%5.83B |
| Income tax | 6.03%8.28B | -4.48%2.45B | 14.18%2.39B | 39.41%7.81B | 23.19%1.56B | 36.84%1.59B | 64.55%2.57B | 29.72%2.1B | -41.55%5.6B | 39.49%1.27B |
| Net income | 20.20%21.05B | 2.21%5.87B | 13.36%5.32B | 16.07%17.51B | -23.16%3.51B | 35.38%3.57B | 95.50%5.74B | -5.17%4.69B | -23.64%15.09B | 381.43%4.56B |
| Net income continuous operations | 20.20%21.05B | 2.21%5.87B | 13.38%5.32B | 16.07%17.51B | -23.14%3.51B | 35.37%3.58B | 95.50%5.74B | -5.17%4.69B | -23.64%15.09B | 381.84%4.56B |
| Noncontrolling interests | 31M | 0 | 0 | 226.13%975M | 0 | |||||
| Net income attributable to the company | 20.02%21.02B | 2.21%5.87B | 13.36%5.32B | 24.09%17.51B | -23.16%3.51B | 35.38%3.57B | 95.77%5.74B | 18.01%4.69B | -31.28%14.11B | 167.84%4.56B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 20.02%21.02B | 2.21%5.87B | 13.36%5.32B | 24.09%17.51B | -23.16%3.51B | 35.38%3.57B | 95.77%5.74B | 18.01%4.69B | -31.28%14.11B | 167.84%4.56B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 19.35%303.83 | 1.64%84.86 | 12.74%77 | 23.33%254.56 | -23.66%50.79 | 34.87%51.98 | 94.57%83.49 | 16.91%68.3 | -34.54%206.4 | 189.26%66.53 |
| Diluted earnings per share | 19.42%303.52 | 1.57%84.8 | 12.74%77 | 23.36%254.16 | -23.92%50.61 | 34.87%51.98 | 95.44%83.49 | 17.31%68.3 | -34.65%206.03 | 189.22%66.52 |
| Dividend per share | 12.50%45 | 10.53%21 | 0 | 14.29%40 | 10.53%21 | 0 | 18.75%19 | 0 | 20.69%35 | 18.75%19 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |